Here’s what you should know.
1. The grant will help the drugmaker continuing refining the aspirin.
2. Lenard M. Lichtenberger, PhD, of Houston-based University of Texas Health Science Center, will serve as principal investigator.
3. The principle study will examine the aspirin’s role in colorectal cancer prevention.
4. The grant will come in two annual installments in 2017 and 2018.
More articles on gastroenterology:
Underwater colonoscopy more effective than air insufflation — 5 insights
Drs. David Ahlquist & Anil Rustgi: 8 GI physicians in the headlines
GI leader to know: Dr. Dino Ferrante of the Center for Colon & Digestive Disease
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
